Artificial intelligence (AI) has shown similar levels of accuracy to ophthalmologists in diagnosing infectious keratitis (IK), a meta-analysis study has found.
Astellas Pharma Inc. has announced it is withdrawing its marketing authorisation application for avacincaptad pegol intravitreal solution from the European Medicines Agency.
A patient has regained perfect vision following an artificial iris transplant completed at Canberra Microsurgery – part of the PresMed Australia Group – using
The federal government has announced that from 1 July 2025, health fund benefits will no longer be available for sight-saving eye intravitreal injections performed
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
